BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34270330)

  • 1. Real-World Data on Adult T-Cell Leukemia/Lymphoma in Latin America: A Study From the Grupo de Estudio Latinoamericano de Linfoproliferativos.
    Malpica L; Enriquez DJ; Castro DA; Peña C; Idrobo H; Fiad L; Prates M; Otero V; Biglione M; Altamirano M; Sandival-Ampuero G; Aviles-Perez U; Meza K; Aguirre-Martinez L; Cristaldo N; Maradei JL; Guanchiale L; Soto P; Viñuela JL; Cabrera ME; Paredes SR; Riva E; Di Stefano M; Noboa A; Choque JA; Candelaria M; Von Glasenapp A; Valvert F; Torres-Viera MA; Castillo JJ; Ramos JC; Villela L; Beltran BE
    JCO Glob Oncol; 2021 Jul; 7():1151-1166. PubMed ID: 34270330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.
    Malpica L; Pimentel A; Reis IM; Gotuzzo E; Lekakis L; Komanduri K; Harrington T; Barber GN; Ramos JC
    Blood Adv; 2018 Mar; 2(6):607-620. PubMed ID: 29545256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zidovudine and Interferon Alfa based regimens for the treatment of adult T-cell leukemia/lymphoma (ATLL): a systematic review and meta-analysis.
    Shafiee A; Seighali N; Taherzadeh-Ghahfarokhi N; Mardi S; Shojaeian S; Shadabi S; Hasani M; Haghi S; Mozhgani SH
    Virol J; 2023 Jun; 20(1):118. PubMed ID: 37287047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult T-Cell Leukemia/Lymphoma: Rarely Encountered in the United States.
    Roe C; Komrokji R; Zhang L; Price S; Sokol L
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S191-4. PubMed ID: 27521318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma.
    Hodson A; Crichton S; Montoto S; Mir N; Matutes E; Cwynarski K; Kumaran T; Ardeshna KM; Pagliuca A; Taylor GP; Fields PA
    J Clin Oncol; 2011 Dec; 29(35):4696-701. PubMed ID: 22042945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.
    Alduaij A; Butera JN; Treaba D; Castillo J
    Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):480-3. PubMed ID: 21156467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international, multicenter, retrospective study on the positive impact of cutaneous involvement on the clinical outcome of adult T-cell leukemia/lymphoma.
    Malpica L; Castro D; Enriquez DJ; Oviedo-Pecho R; Peña C; Idrobo H; Fiad L; Prates M; Valcarcel B; Paredes A; Sánchez G; Moisés C; Castillo JJ; Villela L; Ramos JC; Biglione M; Beltran BE;
    Leuk Lymphoma; 2022 Feb; 63(2):315-325. PubMed ID: 34585997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
    Guery R; Suarez F; Lanternier F; Bougnoux ME; Lecuyer H; Avettand-Fenoel V; Sibon D; Frenzel L; Raphalen JH; Helias P; Renaudier P; Santa F; Lecuit M; Lortholary O; Hermine O; Aguilar C; Marçais A
    Ann Hematol; 2021 Nov; 100(11):2813-2824. PubMed ID: 34387741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.
    Tsukasaki K; Utsunomiya A; Fukuda H; Shibata T; Fukushima T; Takatsuka Y; Ikeda S; Masuda M; Nagoshi H; Ueda R; Tamura K; Sano M; Momita S; Yamaguchi K; Kawano F; Hanada S; Tobinai K; Shimoyama M; Hotta T; Tomonaga M;
    J Clin Oncol; 2007 Dec; 25(34):5458-64. PubMed ID: 17968021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of adult T-cell leukemia-lymphoma by CHOP followed by therapy with antinucleosides, alpha interferon and oral etoposide.
    Besson C; Panelatti G; Delaunay C; Gonin C; Brebion A; Hermine O; Plumelle Y
    Leuk Lymphoma; 2002 Dec; 43(12):2275-9. PubMed ID: 12613513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes.
    Bazarbachi A; Plumelle Y; Carlos Ramos J; Tortevoye P; Otrock Z; Taylor G; Gessain A; Harrington W; Panelatti G; Hermine O
    J Clin Oncol; 2010 Sep; 28(27):4177-83. PubMed ID: 20585095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Antivirals" in the treatment of adult T cell leukaemia- lymphoma (ATLL).
    Fields PA; Taylor GP
    Curr Hematol Malig Rep; 2012 Dec; 7(4):267-75. PubMed ID: 23093306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study on combination therapy with CHOP-Zenapax for HTLV-I associated adult T-cell leukaemia/lymphoma (ATLL).
    Ceesay MM; Matutes E; Taylor GP; Fields P; Cavenagh J; Simpson S; Ho A; Devereux S; Mufti GJ; Pagliuca A
    Leuk Res; 2012 Jul; 36(7):857-61. PubMed ID: 22209076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.
    Taguchi H; Kinoshita KI; Takatsuki K; Tomonaga M; Araki K; Arima N; Ikeda S; Uozumi K; Kohno H; Kawano F; Kikuchi H; Takahashi H; Tamura K; Chiyoda S; Tsuda H; Nishimura H; Hosokawa T; Matsuzaki H; Momita S; Yamada O; Miyoshi I
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):182-6. PubMed ID: 8680890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
    Imaizumi Y; Iwanaga M; Nosaka K; Ishitsuka K; Ishizawa K; Ito S; Amano M; Ishida T; Uike N; Utsunomiya A; Ohshima K; Tanaka J; Tokura Y; Tobinai K; Watanabe T; Uchimaru K; Tsukasaki K;
    Cancer Sci; 2020 Dec; 111(12):4567-4580. PubMed ID: 32976684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Study of Chemotherapy Combined with Antivirals for Adult T-cell Leukemia/Lymphoma].
    Lin Y; Zhang RD; Chen RL; Chen J; Wu Y; Chen Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1407-1414. PubMed ID: 36208242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adult T cell leukemia lymphoma in Chile. A clinical pathologic and molecular study of 26 patients].
    Cabrera ME; Labra S; Meneses P; Matutes E; Cartier L; Ford AM; Greaves MF
    Rev Med Chil; 1999 Aug; 127(8):935-44. PubMed ID: 10752254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.
    Phillips AA; Shapira I; Willim RD; Sanmugarajah J; Solomon WB; Horwitz SM; Savage DG; Bhagat G; Soff G; Zain JM; Alobeid B; Seshan VE; O'Connor OA
    Cancer; 2010 Jul; 116(14):3438-46. PubMed ID: 20564100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Characteristics and Outcomes of Caribbean Patients With Adult T-Cell Lymphoma/Leukemia at Two Affiliated New York City Hospitals.
    Chiu E; Samra B; Tam E; Baseri B; Lin B; Luhrs C; Gonsky J; Sawas A; Taiwo E; Sidhu G
    JCO Glob Oncol; 2020 Apr; 6():548-556. PubMed ID: 32243210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.